A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

NCT06011954 · clinicaltrials.gov ↗

RECRUITING

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Cancer

Interventions

DRUG: Enfortumab Vedotin

Sponsor

Astellas Pharma Korea, Inc.

Collaborators

[object Object]